We have attracted a talented and experienced R&D team, which includes the innovators of many market-leading transdermal therapeutics, who are pioneering the development of new healthcare products at Corium.
Our proprietary and partnered products combine our state of the art transdermal technologies, Corplex™ and MicroCor®, with extensive expertise in polymer blending, formulation and process engineering. This enables Corium scientists to develop novel transdermal products that can efficiently deliver both small molecules and biologics across the skin. Furthermore, our robust patent estate provides long-term competitive advantages and substantial lifecycle management value.
From the outset, our R&D efforts are closely coordinated with our process development team to ensure a smooth and streamlined transition from initial development through scale-up and commercial manufacture. Our approach to process and product development distinguishes us from other transdermal companies and frequently results in faster timelines and economic efficiencies.